Long Term Efficacy and Safety of Mipomersen During 4 Years of Treatment in a Cohort of Patients with Heterozygous Familial Hypercholesterolemia and Coronary Artery Disease (CAD) by Duell, P. Bart, MD, Rose, J.E., RN, Selvey, S., PharmD, Alam, Shushama, PharmD, Mittleman, R., MD

Get full text

Pediatric experience with mipomersen as adjunctive therapy for homozygous familial hypercholesterolemia by Raal, Frederick J., PhD, Braamskamp, Marjet J., MD, PhD, Selvey, Sheryl L., PharmD, Sensinger, Charlotte H., MA, Kastelein, John J., MD, PhD

Get full text

Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study by Pang, Jing, PhD, Sullivan, David R., MD, Harada-Shiba, Mariko, MD, PhD, Ding, Phillip Y.A., MD, PhD, Selvey, Sheryl, PharmD, Ali, Shariq, PhD, Watts, Gerald F., DSc, MD

Get full text

Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces LDL-C in HoFH Pediatric Patients by Selvey, Sheryl, PharmD, Raal, Frederick J

Get full text

Lack of Fetal Harm and Absence of Drug-Drug Interactions Attributed to Unique Pharmacokinetic Properties of Mipomersen by Henry, Scott, PhD, Kim, Tae-Won, PhD, Geary, Richard, PhD, Li, Zhaoyang, PhD, Mahmood, Asif, MD, MPH, MBA, Selvey, Sheryl, PharmD, Alam, Shushama, PharmD

Get full text

Lack of Drug-Drug Interaction between Mipomersen and Warfarin in Healthy Volunteers by Li, Zhaoyang, PhD, Hunt, Thomas L., MD, Hard, Marjie, PhD, Selvey, Sheryl, PharmD, Alam, Shushama, PharmD, Boltje, Ingrid, MD

Get full text